[Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40].
Schneider
R
R
Hacke
W
W
Kiesewetter
H
H
Jung
F
F
D002544:Cerebral Infarction / Q000188:drug therapy*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D003911:Dextrans / Q000627:therapeutic use*; D006438:Hemodilution; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D012212:Rheology; D013213:Starch / Q000031:analogs & derivatives*
D003911:Dextrans; D006895:Hydroxyethyl Starch Derivatives; D013213:Starch
Hämodilution bei akuten ischämischen Insulten. Vergleichende Studie zur klinischen und hämorheologischen Wirksamkeit von 10% HES 200/0.5 und 10% Dextran 40.